Recent studies have shown that PVT1 modulates the expression of HK2 by competing with endogenous miR-143 in gallbladder cancer (GBC) cells, which could provide valuable insights into the potential therapeutic targets for GBC at the molecular level [25]. Here, PVT1 is linked to gallbladder cancer.